{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:30:20Z","timestamp":1787167820556,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2021]]},"DOI":"10.4103\/0028-3886.325385","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T02:16:44Z","timestamp":1640657804000},"page":"1055","source":"Crossref","is-referenced-by-count":1,"title":["Noncontiguous Radiation-Induced Brain Necrosis (RIBN) in a Patient with Aggressive Pituitary Adenoma and the Utility of Bevacizumab"],"prefix":"10.4103","volume":"69","author":[{"given":"Pinaki","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakamya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KanchanK","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivashanmugam","family":"Dhandapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.325385-1","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.325385-2","first-page":"1182","article-title":"Tumor angiogenesis: Therapeutic implications","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.325385-3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo","author":"Kim","year":"1993","journal-title":"Nature"},{"key":"key-10.4103\/0028-3886.325385-4","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1053\/j.seminoncol.2009.02.002","article-title":"Targeting tumor angiogenesis","author":"Gaur","year":"2009","journal-title":"Semin Oncol"},{"key":"key-10.4103\/0028-3886.325385-5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0028-3886.325385-6","doi-asserted-by":"crossref","unstructured":"Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, et al. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: Pathological consideration of their potential roles. J Neurooncol 2011;105:423-31.","DOI":"10.1007\/s11060-011-0610-9"},{"key":"key-10.4103\/0028-3886.325385-7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3171\/2014.9.PEDS14198","article-title":"Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain","author":"Dashti","year":"2015","journal-title":"J Neurosurg Pediatr"},{"key":"key-10.4103\/0028-3886.325385-8","doi-asserted-by":"crossref","unstructured":"Dutta P, Dhandapani S, Kumar N, Gupta P, Ahuja C, Mukherjee KK. Bevacizumab for radiation associated visual decline among aggressive residual\/recurrent suprasellar tumors: More than a mere anti-neoplastic effect. World Neurosurg 2017;107:1044.e5--10.","DOI":"10.1016\/j.wneu.2017.07.111"},{"key":"key-10.4103\/0028-3886.325385-9","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.4103\/2152-7806.179229","article-title":"Trends in cognitive dysfunction following surgery for intracranial tumors","author":"Dhandapani","year":"2016","journal-title":"Surgical neurology international"},{"key":"key-10.4103\/0028-3886.325385-10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000475899","article-title":"Prevalence and trends in the neuropsychological burden of patients having intracranial tumors with respect to neurosurgical intervention","author":"Dhandapani","year":"2017","journal-title":"Annals of neurosciences"},{"key":"key-10.4103\/0028-3886.325385-11","first-page":"1247","article-title":"Visual outcome in 2000 eyes following microscopic transsphenoidal surgery for pituitary adenomas: Protracted blindness should not be a deterrent","author":"Dutta","year":"2016","journal-title":"Neurol India","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3886","issn-type":"print"},{"key":"key-10.4103\/0028-3886.325385-12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fendo.2018.00453","article-title":"Imatinib inhibits GH secretion from somatotropinomas","author":"Gupta","year":"2018","journal-title":"Frontiers in endocrinology"},{"key":"key-10.4103\/0028-3886.325385-13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000411642","article-title":"The risk of cerebral radionecrosis in relation to dose, time and fractionation.A follow-up study","author":"Marks","year":"1985","journal-title":"Prog Exp Tumor Res"},{"key":"key-10.4103\/0028-3886.325385-14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: Mechanisms of anti-tumour activity","author":"Ellis","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"key-10.4103\/0028-3886.325385-15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00066-010-2184-4","article-title":"Bevacizumab as a treatment option for radiation-induced cerebral necrosis","author":"Matuschek","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"key-10.4103\/0028-3886.325385-16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-009-9801-z","article-title":"Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis","author":"Torcuator","year":"2009","journal-title":"J Neurooncol"},{"key":"key-10.4103\/0028-3886.325385-17","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1200\/JCO.2008.19.1866","article-title":"Bevacizumab reverses cerebral radiation necrosis","author":"Wong","year":"2008","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0028-3886.325385-18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11102-011-0346-8","article-title":"Anti-VEGF therapy in pituitary carcinoma","author":"Ortiz","year":"2012","journal-title":"Pituitary"},{"key":"key-10.4103\/0028-3886.325385-19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.0004-8461.2003.01237.x","article-title":"Radiation-induced brain disorders in patients with pituitary tumours","author":"Bhansali","year":"2004","journal-title":"Australas Radiol"},{"key":"key-10.4103\/0028-3886.325385-20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","article-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","author":"Ferrara","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/0028-3886.325385-21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdq702","article-title":"Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab","author":"Tebbutt","year":"2011","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0028-3886.325385-22","doi-asserted-by":"crossref","unstructured":"Mansfield AS, Nevala WK, Lieser EA, Leontovich AA, Markovic SN. The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma. Oncoimmunology 2013;2;e24436.","DOI":"10.4161\/onci.24436"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:28:02Z","timestamp":1787164082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.325385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"alternative-id":["325385"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.325385","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}